A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
NCT00821561 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2010-02-26
Summary
The purpose of this study is to evaluate the efficacy and safety of Nexagon® in subjects with Persistent Epithelial Defects (PED) originally caused by chemical burns.
Conditions
- Persistent Epithelial Defect
Interventions
- DRUG
-
Nexagon®
- DRUG
-
Nexagon® vehicle
Sponsors & Collaborators
-
OcuNexus Therapeutics, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-11-30
- Completion
- 2010-03-31
More Related Trials
-
A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX
NCT00034788 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
NCT02554851 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers
NCT03855514 ·Status: UNKNOWN ·Phase: NA
-
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
NCT02326740 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
NCT02154087 ·Status: TERMINATED ·Phase: PHASE2
-
Pirfenidone and Its Role in Burn Wound Healing
NCT03530150 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
NCT01831804 ·Status: COMPLETED ·Phase: PHASE1
-
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
NCT02973893 ·Status: UNKNOWN ·Phase: PHASE2
-
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
NCT02461641 ·Status: COMPLETED ·Phase: NA
-
Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer
NCT01658618 ·Status: UNKNOWN
-
Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries
NCT06918548 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients
NCT00662831 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds
NCT02602184 ·Status: UNKNOWN ·Phase: PHASE2
-
NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
NCT06020664 ·Status: SUSPENDED ·Phase: PHASE1
-
Study of Subjects With Diabetic Foot Ulcer (DFU)
NCT03153007 ·Status: COMPLETED
-
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
NCT00312364 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Testing of New Treatment for Chronic Leg Wounds
NCT00000431 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers
NCT00740922 ·Status: COMPLETED
-
Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
NCT00318214 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers
NCT06930768 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
NCT06594393 ·Status: RECRUITING ·Phase: PHASE2
-
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
NCT02352480 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
NCT07159282 ·Status: RECRUITING ·Phase: PHASE4
-
Immunonutrition for Diabetic Foot Ulcers
NCT05281562 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
NCT06319287 ·Status: COMPLETED ·Phase: PHASE2